# Expanded Access for Treatment With Imetelstat

> **NCT05937568** · — · APPROVED_FOR_MARKETING · sponsor: **Geron Corporation**

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Imetelstat

## Key facts

- **NCT ID:** NCT05937568
- **Lead sponsor:** Geron Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2024-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05937568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05937568, "Expanded Access for Treatment With Imetelstat". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05937568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*